User profiles for Niklas Worm Andersson

Niklas Worm Andersson

Statens Serum Institut
Verified email at ssi.dk
Cited by 842

Comparative effectiveness of bivalent BA. 4-5 and BA. 1 mRNA booster vaccines among adults aged≥ 50 years in Nordic countries: nationwide cohort study

NW Andersson, EM Thiesson, U Baum, N Pihlström… - bmj, 2023 - bmj.com
Objective To estimate the effectiveness of the bivalent mRNA booster vaccines containing
the original SARS-CoV-2 and omicron BA.4-5 or BA.1 subvariants as the fourth dose against …

Comparative effectiveness of heterologous third dose vaccine schedules against severe covid-19 during omicron predominance in Nordic countries: population based …

NW Andersson, EM Thiesson, U Baum, N Pihlström… - bmj, 2023 - bmj.com
Objective To investigate the comparative vaccine effectiveness of heterologous booster
schedules (ie, three vaccine doses) compared with primary schedules (two vaccine doses) and …

LDL-C reduction with lipid-lowering therapy for primary prevention of major vascular events among older individuals

NW Andersson, G Corn, TL Dohlmann… - Journal of the American …, 2023 - jacc.org
Background Reducing low-density lipoprotein (LDL) cholesterol with lipid-lowering therapy
has consistently been shown to lower the risk of cardiovascular disease in primary …

Fetal safety of chloroquine and hydroxychloroquine use during pregnancy: a nationwide cohort study

NW Andersson, L Skov, JT Andersen - Rheumatology, 2021 - academic.oup.com
Objective The antimalaria 4-aminoquinoline drugs chloroquine and HCQ are used in the
treatment of a wide range of CTDs. Data to inform on the safety of their use in pregnancy are …

Cumulative Incidence of Thiazide-Induced Hyponatremia: A Population-Based Cohort Study

NW Andersson, J Wohlfahrt, B Feenstra… - Annals of Internal …, 2024 - acpjournals.org
Background: According to drug labels, the frequency of thiazide-induced hyponatremia is
unknown or uncommon to very rare (that is, <1 in 10 000 to <1 in 100), but the exact burden …

Safety of heterologous primary and booster schedules with ChAdOx1-S and BNT162b2 or mRNA-1273 vaccines: nationwide cohort study

NW Andersson, EM Thiesson, MV Laursen… - Bmj, 2022 - bmj.com
Objective To assess the risk of adverse events associated with heterologous primary (two
dose) and booster (three dose) vaccine schedules for covid-19 with Oxford-AstraZeneca’s …

Association between use of macrolides in pregnancy and risk of major birth defects: nationwide, register based cohort study

NW Andersson, RH Olsen, JT Andersen - bmj, 2021 - bmj.com
Objective To examine the association between the use of macrolide antibiotics in pregnancy
and the risk of major birth defects. Design Nationwide, register based cohort study. Setting …

Evaluation of association between oral and topical terbinafine use in pregnancy and risk of major malformations and spontaneous abortion

NW Andersson, SF Thomsen, JT Andersen - JAMA dermatology, 2020 - jamanetwork.com
Importance Terbinafine is a commonly used antifungal agent, but safety data of its use in
pregnancy are limited. Objective To examine the association between oral and topical …

Adverse childhood experiences and asthma: trajectories in a national cohort

K Pape, W Cowell, CS Sejbaek, NW Andersson… - Thorax, 2021 - thorax.bmj.com
Objective Research has linked early adverse childhood experiences (ACEs) with asthma
development; however, existing studies have generally relied on parent report of exposure and …

Desloratadine use during pregnancy and risk of adverse fetal outcomes: a nationwide cohort study

NW Andersson, HE Poulsen, JT Andersen - The Journal of Allergy and …, 2020 - Elsevier
Background Desloratadine is a frequently used drug for the treatment of allergic disorders,
which often also require treatment during pregnancy. However, information on the fetal safety …